Boston Scientific will expand its portfolio of products treating gastrointestinal conditions by purchasing EndoChoice Holdings Inc. for $210 million, the company said Tuesday. Boston Scientific—which ...
Zacks Investment Research on MSN
How well is Boston Scientific placed for long-term endoscopy growth?
Boston Scientific’s BSX Endoscopy business is a core component of its MedSurg segment, developing and manufacturing devices to diagnose and treat a broad range of gastrointestinal and pulmonary ...
After acquiring LumenR and EndoChoice, Boston Scientific committed to leaning on its endoscopy business to drive growth company-wide, Trefis reports. Here’s what you need to know. 1. In addition to ...
Boston Scientific is investing $19 million in a new Galway, Ireland-based RoadRunner endoscopy design facility, Galway Advertiser reports. 1. The company said by 2020 it’ll also invest $19 million in ...
This summer, Boston Scientific will lose one of its longest-serving executives as David Pierce heads into retirement after spending his entire career with the medtech giant. Pierce announced at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback